USDA broke ground on new Soil Research buildings in Auburn
On Nov. 28, 2022, the U.S. Department of Agricultureï¾’s Research Service, Auburn University’s College of Agriculture, and the…
On Nov. 28, 2022, the U.S. Department of Agricultureï¾’s Research Service, Auburn University’s College of Agriculture, and the…
On Nov. 28, 2022, the WHO announced that following a series of consultations with global experts, it had…
On Nov. 27, 2022, it was reported a parasite that infects up to one-third of people around the…
On Nov. 24, 2022, researchers Kanta Horie and Chihiro Sato at the Tracy Family SILQ Center at Washington…
On Nov. 22, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorization for the Lucira…
On Nov. 21, 2022, the National Institutes of Health awarded more than $12 million to three institutions for…
On Nov. 21, 2022, the WHO is launching a global scientific process to update the list of priority…
On Nov. 18, 2022, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovidï¾™ (COVID-19 Vaccine (Recombinant…
On Nov. 18, 2022, the Journal of the American Medical Association reported that the U.S. experienced high COVID-19…
On Nov. 18, 2022, the World Organisation for Animal Health announced that Peru had reported its first outbreak…
On Nov. 16, 2022, Pfizer and BioNTech announced that the companies had initiated a Phase 1 study to…
On Nov. 15, 2022, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Nov. 15, 2022, Roche announced that the U.S. Food and Drug Administration had granted Emergency Use Authorization…
On Nov. 15, 2022, the U.S. Food and Drug Administration conditionally approved Panoquell-CA1 (fuzapladib sodium for injection) for…
On Nov. 14, 2022, researchers discovered the pathway by which chronic hyperglycaemia reduces β-cell function. Their data also…
On Nov. 10, 2022, Pfizer and BioNTech announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine…
On Nov. 10, 2022, researchers from the Okinawa Institute of Science and Technology (OIST), in collaboration with K….
On Nov. 9, 2022, researchers at the University of Missouri announced they had identified the highly prevalent, specific…
On Nov. 8, 2022, Novavax announced topline results from its Phase 3 Boosting Trial for the SARS-CoV-2 rS…
On Nov. 5, 2022, the U.S. Department of Agricultureï¾’s Animal Plant Health Inspection Service confirmed the presence of…
On Nov. 4, 2022, the Oregon Department of Agriculture and the U.S. Department of Agricultureï¾’s Animal Plant Health…
On Nov. 4, 2022, Moderna announced that Health Canada had authorized the use of its BA.4/BA.5 Omicron-targeting bivalent…
On Nov. 4, 2022, the U.S. Department of Agriculture’s (USDA) Animal Plant Health Inspection Service (APHIS) confirmed the…
On Nov. 4, 2022, Pfizer and BioNTech announced updated data from a Phase 2/3 clinical trial demonstrating a…
On Nov. 3, 2022, the University of Missouri announced a $1.5 million gift from the Orthopedic Foundation for…
On Nov. 2, 2022, Hologic announced that it had been awarded a $19 million contract from the Biomedical…
On Nov. 2, 2022, AIM ImmunoTech announced that the U.S. Food and Drug Administration had granted Orphan Drug…
On Nov. 1, 2022, the U.S. Department of Agriculture announced it was making $30 million in American Rescue…
On Nov. 1, 2022, Pfizer announced positive top-line data from the Phase 3 clinical trial (NCT04424316) MATISSE (MATernal…
On Nov. 1, 2022, study results published in JAMA found that estimates in this cross-sectional study of 694,660…